The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(4-(Hydroxymethyl)piperidin-1-yl)-1-methyl-2-morpholino-1H-benzo[d]imidazol-6-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4483477
PubChem CID: 138376590
Max Phase: Preclinical
Molecular Formula: C25H30N8O3
Molecular Weight: 490.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(N2CCOCC2)nc2cc(N3CCC(CO)CC3)c(NC(=O)c3cnn4cccnc34)cc21
Standard InChI: InChI=1S/C25H30N8O3/c1-30-21-13-20(28-24(35)18-15-27-33-6-2-5-26-23(18)33)22(31-7-3-17(16-34)4-8-31)14-19(21)29-25(30)32-9-11-36-12-10-32/h2,5-6,13-15,17,34H,3-4,7-12,16H2,1H3,(H,28,35)
Standard InChI Key: LVDMRCKBQDTUEU-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
6.5171 -5.5973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2254 -5.1865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2206 -4.3644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5115 -3.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9258 -3.9515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9347 -5.5923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9335 -6.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6388 -6.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3473 -6.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3461 -5.5858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6363 -5.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0550 -6.8124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7627 -6.4038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9209 -3.1343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6261 -2.7214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2107 -2.7300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5053 -1.7317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7070 -1.9066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9182 -2.4370 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3770 -3.0446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6329 -3.8151 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4297 -3.9791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9701 -3.3665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7112 -2.5984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8086 -5.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8073 -4.3721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0289 -4.1205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5489 -4.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0309 -5.4442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7330 -4.7849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3245 -4.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5109 -4.0754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0996 -4.7819 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5081 -5.4908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3279 -5.4931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7752 -3.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 26 1 0
3 5 1 0
2 6 1 0
6 7 1 0
6 11 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
5 14 1 0
14 15 1 0
14 16 2 0
15 20 2 0
19 17 1 0
17 18 2 0
18 15 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 29 2 0
29 25 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
28 30 1 0
27 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 490.57Molecular Weight (Monoisotopic): 490.2441AlogP: 1.91#Rotatable Bonds: 5Polar Surface Area: 113.05Molecular Species: NEUTRALHBA: 10HBD: 2#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.38CX Basic pKa: 7.22CX LogP: 1.72CX LogD: 1.51Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.44Np Likeness Score: -1.96
References 1. Bryan MC, Drobnick J, Gobbi A, Kolesnikov A, Chen Y, Rajapaksa N, Ndubaku C, Feng J, Chang W, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Huang Z, Sujatha-Bhaskar S, Brightbill H, DiPasquale A, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR.. (2019) Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors., 62 (13): [PMID:31082230 ] [10.1021/acs.jmedchem.9b00439 ]